S&P 500   4,556.90 (+0.14%)
DOW   35,622.86 (+0.54%)
QQQ   390.31 (+0.13%)
AAPL   189.72 (+0.18%)
MSFT   378.45 (-0.11%)
META   332.07 (-0.04%)
GOOGL   135.07 (+0.06%)
AMZN   145.41 (-0.62%)
TSLA   244.30 (+0.07%)
NVDA   481.95 (+0.11%)
NIO   7.25 (+0.97%)
BABA   74.71 (+0.05%)
AMD   124.03 (+0.15%)
T   16.30 (+0.00%)
F   10.69 (+0.94%)
MU   77.03 (+0.44%)
CGC   0.57 (+0.98%)
GE   119.03 (+0.14%)
DIS   92.63 (+0.14%)
AMC   7.17 (+0.00%)
PFE   30.17 (+0.30%)
PYPL   58.11 (+0.24%)
XOM   103.31 (+0.95%)
S&P 500   4,556.90 (+0.14%)
DOW   35,622.86 (+0.54%)
QQQ   390.31 (+0.13%)
AAPL   189.72 (+0.18%)
MSFT   378.45 (-0.11%)
META   332.07 (-0.04%)
GOOGL   135.07 (+0.06%)
AMZN   145.41 (-0.62%)
TSLA   244.30 (+0.07%)
NVDA   481.95 (+0.11%)
NIO   7.25 (+0.97%)
BABA   74.71 (+0.05%)
AMD   124.03 (+0.15%)
T   16.30 (+0.00%)
F   10.69 (+0.94%)
MU   77.03 (+0.44%)
CGC   0.57 (+0.98%)
GE   119.03 (+0.14%)
DIS   92.63 (+0.14%)
AMC   7.17 (+0.00%)
PFE   30.17 (+0.30%)
PYPL   58.11 (+0.24%)
XOM   103.31 (+0.95%)
S&P 500   4,556.90 (+0.14%)
DOW   35,622.86 (+0.54%)
QQQ   390.31 (+0.13%)
AAPL   189.72 (+0.18%)
MSFT   378.45 (-0.11%)
META   332.07 (-0.04%)
GOOGL   135.07 (+0.06%)
AMZN   145.41 (-0.62%)
TSLA   244.30 (+0.07%)
NVDA   481.95 (+0.11%)
NIO   7.25 (+0.97%)
BABA   74.71 (+0.05%)
AMD   124.03 (+0.15%)
T   16.30 (+0.00%)
F   10.69 (+0.94%)
MU   77.03 (+0.44%)
CGC   0.57 (+0.98%)
GE   119.03 (+0.14%)
DIS   92.63 (+0.14%)
AMC   7.17 (+0.00%)
PFE   30.17 (+0.30%)
PYPL   58.11 (+0.24%)
XOM   103.31 (+0.95%)
S&P 500   4,556.90 (+0.14%)
DOW   35,622.86 (+0.54%)
QQQ   390.31 (+0.13%)
AAPL   189.72 (+0.18%)
MSFT   378.45 (-0.11%)
META   332.07 (-0.04%)
GOOGL   135.07 (+0.06%)
AMZN   145.41 (-0.62%)
TSLA   244.30 (+0.07%)
NVDA   481.95 (+0.11%)
NIO   7.25 (+0.97%)
BABA   74.71 (+0.05%)
AMD   124.03 (+0.15%)
T   16.30 (+0.00%)
F   10.69 (+0.94%)
MU   77.03 (+0.44%)
CGC   0.57 (+0.98%)
GE   119.03 (+0.14%)
DIS   92.63 (+0.14%)
AMC   7.17 (+0.00%)
PFE   30.17 (+0.30%)
PYPL   58.11 (+0.24%)
XOM   103.31 (+0.95%)

Acadia Healthcare (ACHC) Stock Forecast & Price Target

$71.92
-0.08 (-0.11%)
(As of 11/29/2023 ET)
Compare
Today's Range
$71.61
$72.88
50-Day Range
$67.57
$78.76
52-Week Range
$66.49
$89.85
Volume
436,816 shs
Average Volume
513,184 shs
Market Capitalization
$6.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$85.71

Acadia Healthcare Consensus Analyst Rating and Stock Price Forecast (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 6 Analyst Ratings

Analysts' Consensus Price Target

$85.71
19.18% Upside
High Forecast$95.00
Average Forecast$85.71
Low Forecast$63.00
TypeCurrent Forecast
11/30/22 to 11/30/23
1 Month Ago
10/31/22 to 10/31/23
3 Months Ago
9/1/22 to 9/1/23
1 Year Ago
11/30/21 to 11/30/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$85.71$87.63$87.38$86.00
Predicted Upside19.18% Upside16.08% Upside15.37% Upside13.39% Upside
Get Acadia Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ACHC and its competitors with MarketBeat's FREE daily newsletter.


ACHC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Acadia Healthcare Stock vs. The Competition

TypeAcadia HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.17
2.67
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside19.18% Upside912.27% Upside4,719.86% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/7/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$99.00 ➝ $94.00+27.94%
9/14/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$83.00 ➝ $85.00+19.31%
5/4/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$95.00+39.58%
4/20/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Sell$75.00 ➝ $63.00-16.32%
3/6/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$87.00 ➝ $80.00+7.48%
3/1/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$92.00 ➝ $88.00+21.36%
12/12/2022Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$90.00 ➝ $95.00+15.50%
(Data available from 11/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












ACHC Price Target - Frequently Asked Questions

What is Acadia Healthcare's consensus rating and price target?

According to the issued ratings of 6 analysts in the last year, the consensus rating for Acadia Healthcare stock is Hold based on the current 1 sell rating, 3 hold ratings and 2 buy ratings for ACHC. The average twelve-month price prediction for Acadia Healthcare is $85.71 with a high price target of $95.00 and a low price target of $63.00. Learn more on ACHC's analyst rating history.

Do Wall Street analysts like Acadia Healthcare more than its competitors?

Analysts like Acadia Healthcare less than other Medical companies. The consensus rating for Acadia Healthcare is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how ACHC compares to other companies.

Does Acadia Healthcare's stock price have much upside?

According to analysts, Acadia Healthcare's stock has a predicted upside of 15.30% based on their 12-month stock forecasts.

What analysts cover Acadia Healthcare?

Acadia Healthcare has been rated by Cantor Fitzgerald, and Royal Bank of Canada in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:ACHC) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -